drugset
drugset / Trial / NCT01178853

Drug-Drug Interaction Study to Assess the Effects of Steady State Pitavastatin 4 mg or Rosuvastatin 40 mg on Steady-State Warfarin in Healthy Adult Volunteers

NCT01178853 ↗

Phase 4 Completed 48 enrolled Kowa Research Institute, Inc.
RandomizedCrossoverOpen-label

Summary

This is a Phase 4, single center, open label, 4 period, 2 treatment, crossover, drug-drug interaction study.

Timeline

Start
2010-07
Primary completion
2010-10
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Pitavastatin Small molecule 4 mg —
Subject Rosuvastatin Small molecule 40 mg —
Subject Warfarin Small molecule 5 mg —

Indications

No indication recorded.